ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection.
Publication
, Preprint
Semmes, EC; Miller, IG; Rodgers, N; Phan, CT; Hurst, JH; Walsh, KM; Stanton, RJ; Pollara, J; Permar, SR
March 17, 2023
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Semmes, E. C., Miller, I. G., Rodgers, N., Phan, C. T., Hurst, J. H., Walsh, K. M., … Permar, S. R. (2023). ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection. https://doi.org/10.1101/2023.03.15.23287332
Semmes, Eleanor C., Itzayana G. Miller, Nicole Rodgers, Caroline T. Phan, Jillian H. Hurst, Kyle M. Walsh, Richard J. Stanton, Justin Pollara, and Sallie R. Permar. “ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection.,” March 17, 2023. https://doi.org/10.1101/2023.03.15.23287332.
Semmes EC, Miller IG, Rodgers N, Phan CT, Hurst JH, Walsh KM, et al. ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection. 2023.
Semmes, Eleanor C., et al. ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection. 17 Mar. 2023. Pubmed, doi:10.1101/2023.03.15.23287332.
Semmes EC, Miller IG, Rodgers N, Phan CT, Hurst JH, Walsh KM, Stanton RJ, Pollara J, Permar SR. ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection. 2023.